210 related articles for article (PubMed ID: 7506447)
1. [Post-transfusional hepatitis in the city of Campinas, SP, Brazil. II. Presence of anti-HBc and anti-HCV antibodies in blood donor candidates and occurrence of post-transfusional hepatitis C in recipients of blood or derivates].
Gonçales Júnior FL; Pedro Rde J; da Silva LJ; Boccato RS; Gonçales NS
Rev Inst Med Trop Sao Paulo; 1993; 35(1):63-71. PubMed ID: 7506447
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence of HBsAg, anti-HBc and anti-HCV in blood donor candidates at the Campinas hemocenter].
Gonçales Júnior FL; Boccato RS; Pedro Rde J; Papaiordanou PM; de Souza CA; Gonçales NS; Pellegrino Júnior J
Rev Inst Med Trop Sao Paulo; 1993; 35(1):45-51. PubMed ID: 7506445
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
[TBL] [Abstract][Full Text] [Related]
4. [Viral hepatitis and blood transfusion].
Larsen J; Hetland G; Skaug K; Maeland A
Tidsskr Nor Laegeforen; 1991 Mar; 111(7):825-8. PubMed ID: 1850559
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
[TBL] [Abstract][Full Text] [Related]
6. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
[TBL] [Abstract][Full Text] [Related]
7. [Post-transfusional hepatitis in the city of Campinas, SP, Brazil. I. Incidence, etiological agents and clinico-epidemiological aspects of hepatitis C].
Gonçales Júnior FL; Pedro Rde J; da Silva LJ; Boccato RS; Ramos MC; Gonçales NS
Rev Inst Med Trop Sao Paulo; 1993; 35(1):53-62. PubMed ID: 7506446
[TBL] [Abstract][Full Text] [Related]
8. The declining risk of post-transfusion hepatitis C virus infection.
Donahue JG; Muñoz A; Ness PM; Brown DE; Yawn DH; McAllister HA; Reitz BA; Nelson KE
N Engl J Med; 1992 Aug; 327(6):369-73. PubMed ID: 1320736
[TBL] [Abstract][Full Text] [Related]
9. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
Alter HJ; Purcell RH; Shih JW; Melpolder JC; Houghton M; Choo QL; Kuo G
N Engl J Med; 1989 Nov; 321(22):1494-500. PubMed ID: 2509915
[TBL] [Abstract][Full Text] [Related]
10. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
Baur P; Roelcke D
Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
[TBL] [Abstract][Full Text] [Related]
11. [Massive and multi-transfusions in polytraumatized patients: long-term serologic markers of hepatitis B, hepatitis C and AIDS].
Schneck HJ; Dobler G; Hundelshausen B; Nathrath M; Drescher M
Infusionstherapie; 1991 Oct; 18(5):248-55. PubMed ID: 1663086
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibody to hepatitis C virus in a blood donor population.
Richards C; Holland P; Kuramoto K; Douville C; Randell R
Transfusion; 1991 Feb; 31(2):109-13. PubMed ID: 1847559
[TBL] [Abstract][Full Text] [Related]
13. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
Chung HT; Lee JS; Lok AS
Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of antibodies to hepatitis C virus in relation to surrogate markers in a blood donor population of Singapore.
Kuperan P; Choon AT; Ding SH; Lee G
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():127-9. PubMed ID: 7533946
[TBL] [Abstract][Full Text] [Related]
15. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of hepatitis B virus markers for surrogate testing of hepatitis C].
Ohto H; Nomura H; Ohmura K; Ishijima A; Okazaki S
Rinsho Byori; 1991 Jan; 39(1):14-7. PubMed ID: 1848910
[TBL] [Abstract][Full Text] [Related]
17. Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion.
Morris JA; Wilcox TR; Reed GW; Hunter EB; Wallas CH; Steane EA; Shotts SD; Vitsky JL
Ann Surg; 1994 May; 219(5):517-25; discussion 525-6. PubMed ID: 7514394
[TBL] [Abstract][Full Text] [Related]
18. A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group.
Pereira BJ; Wright TL; Schmid CH; Levey AS
Lancet; 1995 Feb; 345(8948):484-7. PubMed ID: 7532254
[TBL] [Abstract][Full Text] [Related]
19. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
[TBL] [Abstract][Full Text] [Related]
20. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
